輸血拒否例に対する化学療法でのエリスロポエチン併用の試み

書誌事項

タイトル別名
  • Administration of recombinant erythropoietin to a patient with malignant lymphoma who refused blood transfusion.

この論文をさがす

抄録

A 30-year-old female patient with malignant lymphoma was admitted to the hospital because of large mass in the left pelvic cavity and of severe anemia. Since she had refused blood transfusion (Jehovah's witness), recombinant human erythropoietin (Epo) was used together with both chemotherapy and irradiation; this led to rapid recovery of the anemia and marked reduction of the mass volume. These findings may suggest the possible application of Epo administration as a supportive therapy in treatment of malignancy.

収録刊行物

  • 臨床血液

    臨床血液 31 (10), 1698-1700, 1990

    一般社団法人 日本血液学会

詳細情報 詳細情報について

問題の指摘

ページトップへ